Gotowa bibliografia na temat „Inhibitor”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Inhibitor”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Inhibitor"
Sever, Natasa, Metka Filipic, Joze Brzin i Tamara T. Lah. "Effect of Cysteine Proteinase Inhibitors on Murine B16 Melanoma Cell Invasion in vitro". Biological Chemistry 383, nr 5 (15.05.2002): 839–42. http://dx.doi.org/10.1515/bc.2002.088.
Pełny tekst źródłaJasim, Haider Hadi, Read Abd Al-Hussain i Ahmed Shawqi Sadeq. "Evaluation the Efficiency of Various Types of Corrosion Inhibitors Used for Basrah Water Storage Tanks". Al-Nahrain Journal for Engineering Sciences 23, nr 3 (21.11.2020): 267–76. http://dx.doi.org/10.29194/njes.23030267.
Pełny tekst źródłaKUMAR, Priyadarsini, i Donal A. WALSH. "A dual-specificity isoform of the protein kinase inhibitor PKI produced by alternate gene splicing". Biochemical Journal 362, nr 3 (8.03.2002): 533–37. http://dx.doi.org/10.1042/bj3620533.
Pełny tekst źródłaKrulikas, Linas J., Ian M. McDonald, Benjamin Lee, Denis O. Okumu, Michael P. East, Thomas S. K. Gilbert, Laura E. Herring i in. "Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth". SLAS DISCOVERY: Advancing the Science of Drug Discovery 23, nr 8 (9.05.2018): 850–61. http://dx.doi.org/10.1177/2472555218773045.
Pełny tekst źródłaSuzuki, Suzuki, Morio Arai, Kagehiro Amano, Kazuhiko Kagawa i Katsuyuki Fukutake. "Factor VIII Inhibitor Antibodies with C2 Domain Specificity Are Less inhibitory to Factor VIII Complexed with von Willebrand Factor". Thrombosis and Haemostasis 76, nr 05 (1996): 749–54. http://dx.doi.org/10.1055/s-0038-1650655.
Pełny tekst źródłaALIAS, ZAZALI, i NORA ASYIKIN RAMLI. "PURIFICATION AND PARTIAL CHARACTERISATION OF A PROTEASE INHIBITOR FROM Mimosa diplotricha". Malaysian Applied Biology 51, nr 4 (31.10.2022): 169–75. http://dx.doi.org/10.55230/mabjournal.v51i4.26.
Pełny tekst źródłaLi, Qi, Hongyu Yang, Jun Mo, Yao Chen, Yue Wu, Chen Kang, Yuan Sun i Haopeng Sun. "Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors". PeerJ 6 (26.01.2018): e4206. http://dx.doi.org/10.7717/peerj.4206.
Pełny tekst źródłaArita, Minetaro, Takaji Wakita i Hiroyuki Shimizu. "Cellular kinase inhibitors that suppress enterovirus replication have a conserved target in viral protein 3A similar to that of enviroxime". Journal of General Virology 90, nr 8 (1.08.2009): 1869–79. http://dx.doi.org/10.1099/vir.0.012096-0.
Pełny tekst źródłaCurry, V. A., I. M. Clark, H. Bigg i T. E. Cawston. "Large inhibitor of metalloproteinases (LIMP) contains tissue inhibitor of metalloproteinases (TIMP)-2 bound to 72,000-Mr progelatinase". Biochemical Journal 285, nr 1 (1.07.1992): 143–47. http://dx.doi.org/10.1042/bj2850143.
Pełny tekst źródłaMoon, Hyun-Jung, Su-Hoon Lee, Hak-Bong Kim, Kyoung-A. Lee, Chi-Dug Kang i Sun-Hee Kim. "SIRT1 Inhibitor Enhances Hsp90 Inhibitor-mediated Abrogation of Hsp90 Chaperone Function and Potentiates the Cytotoxicity of Hsp90 Inhibitor in Chemo-resistant Human Cancer Cells". Journal of Life Science 26, nr 7 (30.07.2016): 826–34. http://dx.doi.org/10.5352/jls.2016.26.7.826.
Pełny tekst źródłaRozprawy doktorskie na temat "Inhibitor"
Rodkey, Elizabeth A. "INHIBITOR RESISTANCE MECHANISMS AND INHIBITOR DESIGN IN ¿¿-LACTAMASES". Case Western Reserve University School of Graduate Studies / OhioLINK, 2013. http://rave.ohiolink.edu/etdc/view?acc_num=case1354463033.
Pełny tekst źródłaShkirskiy, Viacheslav. "Corrosion inhibition of galvanized steel by LDH - inhibitor hybrids : Mechanisms of Inhibitor Release and Corrosion Reactions". Thesis, Paris 6, 2015. http://www.theses.fr/2015PA066216/document.
Pełny tekst źródłaThe current work was dedicated to the investigation of the fundamental mechanisms of the action of a layered double hydroxide (LDH) inhibitor hybrid coated systems for the corrosion protection of galvanized steel. The objective of the work was achieved by the realization of three milestones: (1) the identification of the effective water soluble inhibitor on Zn and steel substrates and the understanding the mechanisms of its action, (2) the revealing the factors and mechanisms controlling the release of the selected inhibitor from Zn2Al/-LDH hosts and (3) the understanding the mechanisms of coated system controlled by inhibitor release and its action. MoO42- showed the best inhibition efficiency comparable to CrO42- in alkaline and neutral solutions. The protective properties of MoO42- were assigned to the fast formation of Mo(V) film. The effect of MoO42- on the dissolution of low carbon steel was also verified to exclude the possible accelerating effect of chosen species. The leaching tests showed that MoO42- release from LDH was controlled by the nature of the exchanged ions from the media by ion-exchange mechanism at neutral pH and by the dissolution of the LDH framework at alkaline pH. The presence of only Cl- resulted in less than 40 % of MoO42- release after 24 hours of the immersion while the additions of the carbonates resulted in 100 % release after 1 hour. The immersion tests showed slight inhibiting effect of coated system in Cl and high in CO32- medias coherent with higher level of MoO¬42- released. The ways to control the inhibitor release and hence, the inhibition performance of coated systems were discussed in the vein of environment composition
Hirst, Claire Elizabeth 1971. "Tissue distribution and regulation of the granzyme B inhibitor, proteinase inhibitor 9". Monash University, Dept. of Biochemistry and Molecular Biology, 2002. http://arrow.monash.edu.au/hdl/1959.1/8488.
Pełny tekst źródłaRoweth, Harvey George. "Mechanisms of platelet inhibition by the selective serotonin reuptake inhibitor citalopram". Thesis, University of Cambridge, 2018. https://www.repository.cam.ac.uk/handle/1810/275477.
Pełny tekst źródłaGuzanov, Pavel. "ERAP1 inhibitor development". Thesis, University of Oxford, 2017. https://ora.ox.ac.uk/objects/uuid:e4369016-ab8f-445d-ab1a-71129b495a37.
Pełny tekst źródłaClarke, Tyler Brooke. "Studies on the inhibitor selectivity and inhibitory signal transfer of a-Isopropylmalate synthase". Thesis, University of Canterbury. Chemistry, 2013. http://hdl.handle.net/10092/11303.
Pełny tekst źródłaMenon, V. "Molecular and functional aspects of hydrolyases / inhibitors with emphasis on aspartic protease inhibitor". Thesis(Ph.D.), CSIR-National Chemical Laboratory, Pune, 2012. http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/2401.
Pełny tekst źródłaMiyazaki, Hiroshi. "Studies on Inhibitors of Plasminogen Activator Inhibitor-1(PAI-1) and Inhibitors of PAI-1 Production as Antithrombotic Agents". 京都大学 (Kyoto University), 2010. http://hdl.handle.net/2433/126818.
Pełny tekst źródłaAhtyamova, Daria. "Cholinesterase inhibitor: pharmacological application". Thesis, Київський національний університет технологій та дизайну, 2019. https://er.knutd.edu.ua/handle/123456789/13033.
Pełny tekst źródłaMcCready, Tara Lyn. "Inhibition of protein phosphatase-1 by endogenous inhibitor proteins and natural product toxins". Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape7/PQDD_0032/NQ46885.pdf.
Pełny tekst źródłaKsiążki na temat "Inhibitor"
Li, Rongshi, i Jeffrey A. Stafford, red. Kinase Inhibitor Drugs. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2009. http://dx.doi.org/10.1002/9780470524961.
Pełny tekst źródłaA, Stafford Jeffrey, red. Kinase inhibitor drugs. Hoboken, N.J: J. Wiley, 2009.
Znajdź pełny tekst źródłaChang, Henry E. HIV protease inhibitor report. Wyd. 2. Brooklyn, NY (72 Orange St., #3C, Brooklyn 11201): National AIDS Treatment Advocacy Project, 1996.
Znajdź pełny tekst źródłaBashein, Abdulla Masood. Vitreous-derived inhibitor of angiogenesis. Manchester: University of Manchester, 1995.
Znajdź pełny tekst źródłaC, Shirley Anne, red. Trends in serotonin uptake inhibitor research. Hauppauge, NY: Nova Science Pub., 2004.
Znajdź pełny tekst źródłaKrämer, Oliver H., red. HDAC/HAT Function Assessment and Inhibitor Development. New York, NY: Springer US, 2023. http://dx.doi.org/10.1007/978-1-0716-2788-4.
Pełny tekst źródłaKrämer, Oliver H., red. HDAC/HAT Function Assessment and Inhibitor Development. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6527-4.
Pełny tekst źródłaLendeckel, Uwe, i Nigel M. Hooper, red. Viral Proteases and Antiviral Protease Inhibitor Therapy. Dordrecht: Springer Netherlands, 2009. http://dx.doi.org/10.1007/978-90-481-2348-3.
Pełny tekst źródłaMiskei, Gyorgy Zsolt. Studies on lung lavage alphai proteinase inhibitor. Birmingham: University of Birmingham, 1998.
Znajdź pełny tekst źródłaH, Kennedy Sidney, red. Clinical advances in monoamine oxidase inhibitor therapies. Washington, DC: American Psychiatric Press, 1994.
Znajdź pełny tekst źródłaCzęści książek na temat "Inhibitor"
Weik, Martin H. "inhibitor". W Computer Science and Communications Dictionary, 782. Boston, MA: Springer US, 2000. http://dx.doi.org/10.1007/1-4020-0613-6_8998.
Pełny tekst źródłaGooch, Jan W. "Inhibitor". W Encyclopedic Dictionary of Polymers, 388. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-6247-8_6312.
Pełny tekst źródłaBährle-Rapp, Marina. "Inhibitor". W Springer Lexikon Kosmetik und Körperpflege, 280. Berlin, Heidelberg: Springer Berlin Heidelberg, 2007. http://dx.doi.org/10.1007/978-3-540-71095-0_5204.
Pełny tekst źródłaDavis, Alvin E. "C1 Inhibitor". W Advances in Experimental Medicine and Biology, 185–94. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4615-5391-5_18.
Pełny tekst źródłaMakkar, Harinder P. S., P. Siddhuraju i Klaus Becker. "Trypsin Inhibitor". W Plant Secondary Metabolites, 1–6. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-425-4_1.
Pełny tekst źródłaMakkar, Harinder P. S., P. Siddhuraju i Klaus Becker. "Chymotrypsin Inhibitor". W Plant Secondary Metabolites, 7–9. Totowa, NJ: Humana Press, 2007. http://dx.doi.org/10.1007/978-1-59745-425-4_2.
Pełny tekst źródłaLahiri, Cecile Delille, Jeffrey Lennox i Ighovwerha Ofotokun. "Protease Inhibitor". W Encyclopedia of AIDS, 1–8. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4614-9610-6_443-1.
Pełny tekst źródłaKapadia, Shashi, i Marshall J. Glesby. "Maturation Inhibitor". W Encyclopedia of AIDS, 1–5. New York, NY: Springer New York, 2015. http://dx.doi.org/10.1007/978-1-4614-9610-6_452-1.
Pełny tekst źródłaFloresco, Stan, Robert Kessler, Ronald L. Cowan, Robert Kessler, Ronald L. Cowan, Mark Slifstein, Andrea Cipriani i in. "Receptor Inhibitor". W Encyclopedia of Psychopharmacology, 1126. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_4503.
Pełny tekst źródłaHoyer, Daniel, Eric P. Zorrilla, Pietro Cottone, Sarah Parylak, Micaela Morelli, Nicola Simola, Nicola Simola i in. "COMT Inhibitor". W Encyclopedia of Psychopharmacology, 324. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_948.
Pełny tekst źródłaStreszczenia konferencji na temat "Inhibitor"
Booth, N. A., A. Reith i B. Bennett. "A PLASMINOGEN ACTIVATOR INHIBITOR (PAI-2) CIRCULATES IN TWO HIGH MOLECULAR WEIGHT FORMS IN PREGNANCY". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644459.
Pełny tekst źródłaBeretz, A., F. Lanza, A. Stierlé i J.-P. Cazenave. "CYCLIC NUCLEOTIDE PHOSPHODIESTERASE INHIBITORS PREVENT AGGREGATION AND SECRETION OF HUMAN PLATELETS BY RAISING CYCLIC AMP AND REDUCING CYTOPLASMIC FREE CALCIUM MOBILIZATION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643586.
Pełny tekst źródłaLiu, Keshun, i Mike Woolman. "Developing an optimized method for measuring chymotrypsin inhibitor activity in protein products". W 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/yucc6741.
Pełny tekst źródłaSaeki, T., K. HARADA, T. Youshimura, Y. Nakamura, T. Fujimori, K. E. Katayama, Y. Yamagish, I. Yamastu i I. Ikeda. "MODE OF ACTION OF A NOVEL ANTI-PLATELET AGENT (E-5510)". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643427.
Pełny tekst źródłaTans, G., T. Janssen-Claessen, J. Rosing i J. H. Griffin. "APPLICATION OF SPECIFIC SERINE PROTEASE INHIBITORS IN ASSAYS FOR ACTIVATED CONTACT FACTORS." W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643301.
Pełny tekst źródłaSteinert, Bruce W., James M. Onoda, Bonnie F. Sloane, John D. Taylor i Kenneth V. Honn. "CYCLOOXYGENASE AND LIPOXYGENASE PRODUCTS SYNERGISTICALLY MODULATE TUMOR CELL INDUCED PLATELET AGGREGATION". W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644668.
Pełny tekst źródłaJansen, J. W. C. M. "EFFECTS OF INHIBITORS ON COLLAGEN INDUCED PLATELET AGGREGATION IN SIX DIFFERENT SPECIES." W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643445.
Pełny tekst źródłaAlbaiz, A., T. Almubarak, F. Alissa, A. Owais i N. Aljeaban. "Calcium Sulfate Scale Inhibitor: Does the Carbon Backbone Length Matter?" W International Petroleum Technology Conference. IPTC, 2024. http://dx.doi.org/10.2523/iptc-23506-ea.
Pełny tekst źródłaDonaldson, V. H., i M. D. B. H. Mitchell. "INTERACTIONS OF DYSFUNCTIONAL Cl-INHIBITORS FROM PATIENTS WITH TYPE II HEREDITARY ANGIONEUROTIC EDEMA (HANE) WITH ACTIVATED HAGEMAN FACTOR (FACTOR XIIa)." W XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643302.
Pełny tekst źródłaDai, Chong, Zhaoyi Dai, Samiridhdi Paudyal, Saebom Ko, Yue Zhao, Xin Wang, Xuanzhu Yao, Amy Kan i Mason Tomson. "New Kinetic Turbidity Test Method and Prediction Model for Calcite Inhibition". W SPE International Conference on Oilfield Chemistry. SPE, 2021. http://dx.doi.org/10.2118/204398-ms.
Pełny tekst źródłaRaporty organizacyjne na temat "Inhibitor"
Lance, Richard, i Xin Guan. Variation in inhibitor effects on qPCR assays and implications for eDNA surveys. Engineer Research and Development Center (U.S.), sierpień 2021. http://dx.doi.org/10.21079/11681/41740.
Pełny tekst źródłaBeavers, Gui i Sridhar. PR-186-073508-R01 Environmental and Stress Factors that Produce SCC in Existing Ethanol Facilities. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), luty 2011. http://dx.doi.org/10.55274/r0010441.
Pełny tekst źródłaSisler, Edward C., Raphael Goren i Akiva Apelbaum. Controlling Ethylene Responses in Horticultural Crops at the Receptor Level. United States Department of Agriculture, październik 2001. http://dx.doi.org/10.32747/2001.7580668.bard.
Pełny tekst źródłaWilmarth, W. R. Results of Aluminosilicate Inhibitor Testing. Office of Scientific and Technical Information (OSTI), czerwiec 2001. http://dx.doi.org/10.2172/782672.
Pełny tekst źródłaRochelle, J. KH-30 Parafin Inhibitor Treatment. Office of Scientific and Technical Information (OSTI), wrzesień 2001. http://dx.doi.org/10.2172/793837.
Pełny tekst źródłaBanda, Michael J. Novel Breast Tumor Metalloproteinase Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, październik 2002. http://dx.doi.org/10.21236/ada411303.
Pełny tekst źródłaBanda, Michael J. Novel Breast Tumor Metalloproteinase Inhibitor. Fort Belvoir, VA: Defense Technical Information Center, październik 2000. http://dx.doi.org/10.21236/ada392495.
Pełny tekst źródłaBeen, Lu i King. 3DWXATZ Inhibitive Effect of Organics on Near-neutral pH SCC. Chantilly, Virginia: Pipeline Research Council International, Inc. (PRCI), styczeń 2008. http://dx.doi.org/10.55274/r0011184.
Pełny tekst źródłaBowes, Kevin M., John Buffin, Richard Kamin i Douglas Mearns. Fuel System Icing Inhibitor Concentration Reduction Study. Fort Belvoir, VA: Defense Technical Information Center, listopad 2013. http://dx.doi.org/10.21236/ada618863.
Pełny tekst źródłaNaim, Michael, Andrew Spielman, Shlomo Nir i Ann Noble. Bitter Taste Transduction: Cellular Pathways, Inhibition and Implications for Human Acceptance of Agricultural Food Products. United States Department of Agriculture, luty 2000. http://dx.doi.org/10.32747/2000.7695839.bard.
Pełny tekst źródła